FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A ...
Luca Antonelli, MD; Davide Ardizzone, MD; Isamu Tachibana, MD; Nabil Adra, MD; Clint Cary, MD; Lee Hugar, MD; Wade J. Sexton, MD; Aditya Bagrodia, MD; Michal Mego, MD ...
TUESDAY, Nov. 5, 2024 (HealthDay News) -- Open primary retroperitoneal lymph node dissection (RPLND) has an acceptable morbidity profile in men with testicular cancer, according to a study published ...
RIYADH, Saudia Arabia, Dec. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has achieved a groundbreaking medical milestone in the Middle East by ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer. The addition of retroperitoneal ...
With the goals of informing surgical management, improving long-term outcomes and lowering death rates of patients with testicular cancer, a study has found that the conventional, versatile open ...
Colorectal cancer (CRC) remains one of the most prevalent malignancies worldwide, and its management becomes increasingly complex when para‐aortic lymph node metastasis (PALNM) is present. Although ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback